ANTI-AGING · PEPTIDE BLEND
What is GLOW?
Medically reviewed by the G1 Peptides clinical team · Updated October 1, 2026
THE SHORT ANSWER
GLOW is a compounded blend of three peptides: GHK-Cu, BPC-157 and TB-500. GHK-Cu is studied for skin and collagen, and the other two for tissue repair. It is positioned for skin quality and recovery.
GLOW at a glance
- Type
- Peptide blend
- Also known as
- GLOW blend, GHK-Cu + BPC-157 + TB-500
- Mechanism
- GHK-Cu (collagen signalling) + BPC-157 + TB-500 (tissue repair)
- Status
- Compounded (Rx)
- Half-life
- Minutes to hours (by component)
- Route
- Subcutaneous
- Dosing range in the literature
- 1–3.5 mg total per dose
- Onset
- 2–6 weeks
- Storage
- Refrigerated (2–8 °C); use within the pharmacy beyond-use date; blue tint is normal
How GLOW works
GHK-Cu is a copper-binding peptide that signals collagen and elastin production. BPC-157 and TB-500 act on blood-vessel growth and cell migration. The blend delivers all three in a fixed ratio.
What GLOW is studied for
- Skin & collagen
- Tissue repair
- Scar and hair support
Each ingredient has its own laboratory and animal evidence. The blend has not been tested as a combination in controlled human trials.
Being studied for something is not proof that it works. Results in individuals vary.
GLOW dosing
Published protocols describe 1–3.5 mg total per dose, daily or several times weekly, given subcutaneous. Onset is typically reported at 2–6 weeks.
These figures are context from the literature, not instructions. A licensed provider sets the dose and schedule for each patient.
GLOW side effects and risks
- Stinging on injection
- Injection-site reactions
Tell your provider about every medication and condition before starting, and report anything unexpected. See peptide side effects and safety and who should not use peptides.
Is GLOW FDA approved?
A compounded preparation. None of the components is FDA-approved as an injectable.
Approval and trial status change. This page was last reviewed on October 1, 2026.
GLOW at G1 Peptides
G1 Peptides supplies GLOW as vials (70 mg blend) and in pens (GLOW, KLOW). Prescription products ship only after a licensed provider has reviewed the order.
GLOW questions
- What is GLOW?
- GLOW is a compounded blend of three peptides: GHK-Cu, BPC-157 and TB-500. GHK-Cu is studied for skin and collagen, and the other two for tissue repair. It is positioned for skin quality and recovery.
- What is GLOW used for?
- GLOW is studied for skin & collagen, tissue repair, and scar and hair support. Each ingredient has its own laboratory and animal evidence. The blend has not been tested as a combination in controlled human trials.
- How does GLOW work?
- GHK-Cu is a copper-binding peptide that signals collagen and elastin production. BPC-157 and TB-500 act on blood-vessel growth and cell migration. The blend delivers all three in a fixed ratio.
- Is GLOW FDA approved?
- A compounded preparation. None of the components is FDA-approved as an injectable.
- What is the typical GLOW dosage?
- Published protocols describe 1–3.5 mg total per dose, given subcutaneous. This is context from the literature, not a recommendation: a licensed provider sets the dose.
- What are the side effects of GLOW?
- Risks noted for GLOW include stinging on injection and injection-site reactions. Tell your provider about your medications and conditions before starting.
- How long do the peptides in GLOW last in the body?
- The reported half-life is minutes to hours (by component). Onset is typically reported at 2–6 weeks.
- How should GLOW be stored?
- Refrigerated (2–8 °C); use within the pharmacy beyond-use date; blue tint is normal.
For educational purposes only, and not medical advice. These statements have not been evaluated by the FDA. Nothing on this page is intended to diagnose, treat, cure, or prevent any disease. Use any compound only under the guidance of a licensed provider.